Dozens of U.S. Clinics Sell Unproven Stem Cell Therapies for Heart Failure

July 26, 2017

(Reuters) – Stem cell therapy isn’t approved to treat heart failure in the U.S., but dozens of clinics nationwide advertise the treatments anyway, often charging thousands of dollars for procedures that may not be safe or effective, a new study suggests. Researchers found 61 centers offering stem cell therapies for heart failure as of last year in the U.S. alone, including five that claimed to have performed more than 100 procedures. Only nine centers required copies of patients’ medical records and just one facility said it had a board certified cardiologist on staff.